Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Organon and Lexicon Genetics Collaborate to Develop Biotherapeutics Drugs
- OSS, The Netherlands & THE WOODLANDS, Texas -- Lexicon Genetics Incorporated (Nasdaq: LEXG) and Organon, the human healthcare business of Akzo Nobel (Nasdaq: AKZOY), announced the formation of a collaboration to jointly discover, develop and commercialize novel biotherapeutics. The collaboration is designed to combine Lexicon's target discovery and biotherapeutics capabilities...
- Research articles 2005-05-23
- Lexicon Genetics and Takeda establish collaboration to develop new drugs for high blood pressure.(Lexicon Genetics Inc.)(Takeda Pharmaceuticals)
- Lexicon Genetics, Inc. (The Woodlands, TX) and Takeda Pharmaceutical Company Limited (Osaka, Japan) announced the formation of a collaboration to develop new drugs for the treatment of high blood pressure. The alliance is designed to accelerate the development and commercialization of new drugs directed against promising...
- Research articles 2004-07-01
- DUPONT PHARMACEUTICALS
- DUPONT PHARMACEUTICALS has subscribed to Lexicon Genetics Inc.'s Omnibank gene sequence database for a library of mouse embryonic stem ES cells. In exchange, Lexicon receives fees associated with the development of the mutant mice and royalties from products developed by DuPont's drug discovery program with Lexicon...
- Research articles 1998-08-24
Additional Resources
- Lexicon Genetics extends gene targeting technology agreement.(OmniBank Universal)(Boehringer Ingelheim Pharmaceuticals Inc.)(Brief Article)
- Lexicon Genetics, Inc. (The Woodlands, TX) has extended its OmniBank Universal agreement with Boehringer Ingelheim Pharmaceuticals, Inc. Under the terms of the agreement, Boehringer Ingelheim will continue its access to Lexicon's OmniBank library through February 2004. Boehringer Ingelheim will also continue to have access...
- Research articles 2003-03-01
- Zacks Analyst Blog Highlights: Hi-Tech Pharmacal, Hilton, Marriott, Starwood and Lexicon Genetics
- CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day, the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Hi-Tech Pharmacal (Nasdaq: HITK), Hilton (NYSE: HLT), Marriott (NYSE: MAR), Starwood...
- Research articles 2006-11-02
- Lexicon and Genentech Announced Completion of Second Performance Milestone and Sepracor to offer Convertible Senior Subordinated Notes.
- M2 PRESSWIRE-17 September 2004-Financial Relations Inc: Lexicon and Genentech Announced Completion of Second Performance Milestone and Sepracor to offer Convertible Senior Subordinated NotesC1994-2004 M2 COMMUNICATIONS LTD RDATE:09172004 City of Industry, CA - Lexicon Genetics Incorporated (Nasdaq: LEXG) announced today the...
- Research articles 2004-09-17
- Randall Riggs
- Randall Riggs has been appointed vice president of business development at BioCryst Pharmaceuticals Inc. He had held an executive position with Lexicon Genetics Inc.
- Research articles 2005-02-28
- On RadioWallStreet.com: Portfolio Talk With Antony Milford and Deane Donnigan
- Business Editors/Hi-Tech Writers Philadelphia--BUSINESS WIRE--July 20, 2000 Today, on RadioWallStreet.com, Munder Framlington Healthcare Co- Portfolio Managers, Antony Milford & Deane Donnigan, discuss their investment strategy, with reference to Lexicon Genetics Incorporated (Nasdaq: LEXG), Cubist Pharmaceuticals, Inc. (Nasdaq: CBST), Genomic Solutions Inc. (Nasdaq: GNSL), Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM),...
- Research articles 2000-07-20
- TheSUBWAY.coms Stock Market Standouts List for Thursday, February 22, 2007:.
- M2 PRESSWIRE-22 February 2007-Capital Research Group: TheSUBWAY.coms Stock Market Standouts List for Thursday, February 22, 2007:C1994-2007 M2 COMMUNICATIONS LTD RDATE:22022007 TheSUBWAY.com: Announces the following stocks to its Stock Market Standouts List: Stem Cell Innovations, Inc. (OTCBB: SCLL), Intel Corporation (Nasdaq:INTC),...
- Research articles 2007-02-22
- Biotechs UP: Today's Early Performers - Terra Nostra (OTCBB: TNRL) Board Additions.
- M2 PRESSWIRE-12 November 2003-OTC Market News: Biotechs UP: Today's Early Performers - Terra Nostra (OTCBB: TNRL) Board AdditionsC1994-2003 M2 COMMUNICATIONS LTD RDATE:11122003 Biotech leaders out the gate today: Lexicon Genetics (Nasdaq: LEXG), PHARMOS CP (Nasdaq: PARS), GENTA INC (Nasdaq: GNTA), AM...
- Research articles 2003-11-12
- << Previous
- page 1 of 1
- Next >>
